Minnesota to expand medical marijuana program

Tue 12-3-2019

ST. PAUL, Minn. (AP) — Minnesota is expanding the state’s medical marijuana program to include chronic pain and age-related macular degeneration as conditions that can qualify for treatment, state health officials said Monday.

The state Department of Health also said it would allow more sites where patients can access medical cannabis. The changes take effect in August.

Pills, vapors, topical ointments and liquid gels had been the only forms people could obtain through licensed manufacturers. Starting next summer, new delivery methods will include water-soluble cannabinoid, such as powders or sprinkles, and products such as lozenges, gums, mints and tablets.

In addition, LeafLine Labs and Minnesota Medical Solutions — the two licensed manufacturers — will be allowed to open a combined eight more centers in Minnesota. The Health Department said the proposed centers are in Blaine, Burnsville, Duluth, Golden Valley, Mankato, Rogers, Willmar and Woodbury.